Methods of modulating tyrosine protein kinase function with indolinone compounds
AssigneeSugen, Inc.
InventorsPeng Cho Tang, Li Sun
Life of this patent
Estimating the term…
Abstract
The invention relates to certain indolinone compounds, their method of synthesis, and a combinatorial library consisting of the indolinone compounds. The invention also relates to methods of modulating the function of protein tyrosine kinases using indolinone compounds and methods of treating diseases by modulating the function of protein tyrosine kinases and related signal transduction pathways.
Claims39
An indolinone compound having a structure set forth in formula I:
- 54
- wherein
- (A) Q is an optionally substituted oxindole moiety bonded with the rest of the molecule through position 3 of the oxindole ring;
- and
- (B) T is a ring moiety having the structure set forth in formula III:
- 55
- wherein
- (a) R4, R5, R6, and R7 are independently selected from the group consisting of
- (i) hydrogen;
- (ii) saturated or unsaturated alkyl optionally substituted with one or more substituents independently selected from the group consisting of halogen, trihalomethyl, carboxylate, nitro, ester, and a five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moiety, wherein said ring moiety is optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester moieties;
- (iii) an aromatic or heteroaromatic ring optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, and ester moieties;
- (iv) an aliphatic or heteroaliphatic ring optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, ester, and an aromatic or heteroaromatic ring optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, and ester moieties;
- (v) an amine of formula —(X1)n1—NX2X3, wherein X1 is selected from the group consisting of saturated or unsaturated alkyl and five-membered or six-membered aromatic, heteroaromatic, or aliphatic ring moieties and wherein n1 is 0 or 1, and wherein X2 and X3 are independently selected from the group consisting of hydrogen, saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, or aliphatic ring moieties;
- (vi) a nitro of formula —NO2;
- (vii) a halogen or trihalomethyl;
- (viii) a ketone of formula —(X4)n4—CO—X5, wherein X4 and X5 are independently selected from the group consisting of alkyl optionally substituted with halogen, trihalomethyl, carboxylate, nitro, ester, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring moieties are optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester moieties and wherein n4 is 0 or 1;
- (ix) a carboxylic acid of formula —(X6)n6—COOH or ester of formula —(X7)n7—COO—X8, wherein X6, X7, and X8 and are independently selected from the group consisting of alkyl and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties and wherein n6 and n7 are independently 0 or 1;
- (x) an alcohol of formula —(X9)n9—OH or an alkoxyalkyl moiety of formula —(X10)n10—O—X11, wherein X9, X10, and X11 are independently selected from the group consisting of saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester and wherein n9 and n10 are independently 0 or 1;
- (xi) an amide of formula —(X12)n12—NHCOX13, or of formula —(X14)n14—CONX15X16, wherein X12 and X14 are each independently selected from the group consisting of alkyl, hydroxyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester and wherein n12 and n14 are independently 0 or 1, and wherein X13, X14, X15, and X16 are each independently selected from the group consisting of hydrogen, alkyl, hydroxyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester;
- (xii) a sulfonamide of formula —(X17)n17—SO2NX18X19, wherein X17 is selected from the group consisting of alkyl, five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, or ester, and wherein X18, and X19 are independently selected from the group consisting of hydrogen, alkyl, five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, or ester, and wherein X18 and X19 taken together form a five-membered or six-membered aliphatic or heteroaliphatic ring optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester, and wherein n17 is 0 or 1;
- (xiii) an aldehyde of formula —(X20)n20—CO—H wherein X20 is selected from the group consisting of saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester and wherein n20 is 0 or 1;
- (xiv) a sulfone of formula —(X21)n21—SO2—X22, wherein X22 is selected from the group consisting of hydroxide, saturated or unsaturated alkyl and five-membered or six-membered aryl or heteroaryl moieties and wherein X21 is selected from the group consisting of saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester and wherein n21 is 0 or 1;
- and
- (xv) a thiol of formula —(X23)n23—SH or a thioether of formula —(X24)n24—S—X25, wherein X23 and X24 are independently selected from the group consisting of saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester, and wherein n23 and n24 are independently 0 or 1, and wherein X25 is selected from the group consisting of hydrogen, saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester;
- (b) X is selected from the group consisting of NX26, sulfur, SO, SO2, and oxygen, wherein X26 is selected from the group consisting of
- (i) hydrogen;
- (ii) saturated or unsaturated alkyl optionally substituted with a five-membered or six-membered aryl or heteroaryl ring moiety, wherein said ring moiety is optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester moieties;
- (iii) an aryl optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, and ester moieties;
- (iv) a sulfone of formula —SO2—X27, wherein X27 is selected from the group consisting of saturated or unsaturated alkyl and five-membered or six-membered aryl or heteroaryl moieties;
- and
- (v) an acyl of formula —C(O)X28, wherein X28 is selected from the group consisting of hydrogen, saturated and unsaturated alkyl, aryl, and a five-membered or six-membered ring moiety;
- c) ring Y is selected from the group consisting of five-membered, six-membered, and seven-membered aromatic, heteroaromatic, or non-aromatic rings, wherein said heteroaromatic ring contains a heteroatom selected from the group consisting of nitrogen, oxygen, and sulfur, and wherein said non-aromatic ring in combination with R4 optionally forms a carbonyl functionality;
- (d) G, J, and L are selected from the group consisting of carbon and nitrogen;
- and
- (e) T is bonded to the rest of the molecule at the position of the ring marked with an asterisk (*) in formula III.
The method of claim 41, wherein said organism is a mammal.
An oxindole compound of formula V
- 58
- wherein R8 is selected from the group consisting of
- (i) saturated alkyl, optionally substituted with a substituent selected from the group consisting of alkoxy, trihalomethyl, nitro, and cyano moieties, provided that said alkyl is not methyl;
- (ii) an amine of formula —(X1)n1—NX2X3, wherein X1 is selected from the group consisting of saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, or aliphatic ring moieties and wherein n1 is 0 or 1, and wherein X2 and X3 taken together form a 5-membered or 6-membered heteroaliphatic ring;
- (iii) an iodine;
- (iv) a ketone of formula —(X4)n4—CO—X5, wherein X4 and X5 are independently alkyl and wherein n4 is 0 or 1;
- (v) a carboxylic acid of formula —(X6)n6—COOH or ester of formula —(X7)n7—COO—X8, wherein X6, X7, and X8 and are independently selected from the group consisting of alkyl and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties and wherein n6 and n7 are independently 0 or 1;
- (vi) an amide of formula —(X12)n12—NHCOX13, or of formula —(X14)n14—CONX18X16, wherein X12 and X14 are each independently selected from the group consisting of alkyl, hydroxyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester and wherein n12 and n14 are independently 0 or 1, and wherein X13, X15, and X16 are each independently selected from the group consisting of hydrogen, alkyl, hydroxyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester;
- and
- (vii) a sulfonamide of formula —(X17)n17—SO2NX18X19, wherein X17 is selected from the group consisting of alkyl, five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, or ester, and wherein X18, and X19 are independently selected from the group consisting of hydrogen, alkyl, five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, or ester, and wherein X18 and X19 taken together form a five-membered or six-membered aliphatic or heteroaliphatic ring optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester and where n17 is 0 or 1.
An oxindole compound of formula VI
- 61
- wherein R9 is selected from the group consisting of
- (i) an amine of formula —(X1)n1—NX2X3, wherein X1, X2, and X3 are independently selected from the group consisting of hydrogen, saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, or aliphatic ring moieties and wherein n1 is 0 or 1;
- (ii) a nitro of formula —NO2;
- (iii) a chlorine, bromine, or iodine;
- (iv) a ketone of formula —(X4)n4—CO—X5, wherein X4 and X5 are independently selected from the group consisting of alkyl optionally substituted with halogen, trihalomethyl, carboxylate, nitro, ester, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring moieties are optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester moieties and wherein n4 is 0 or 1;
- (v) a carboxylic acid of formula —(X6)n6—COOH or ester of formula —(X7)n7—COO—X8, wherein X6, X7, and X8 and are independently selected from the group consisting of alkyl and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties and wherein n6 and n7 are independently 0 or 1;
- (vi) an amide of formula —(X12)n12—NHCOX13, or of formula —(X14)n14—CONX15X16, wherein X12 and X14 are each independently selected from the group consisting of alkyl and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester and wherein n12 and n14 are independently 0 or 1, and wherein X13, X15, and X16 are each independently selected from the group consisting of hydrogen, alkyl, hydroxyl, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring is optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester;
- and
- (vii) a sulfonamide of formula —(X17)n17—SO2NX18X19, wherein X17 is selected from the group consisting of alkyl, five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, or ester, and wherein X18, and X19 are independently selected from the group consisting of hydrogen, alkyl, five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, or ester, and wherein X18 and X19 taken together form a five-membered or six-membered aliphatic or heteroaliphatic ring optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester and where n17 is 0 or 1.
An oxindole compound of formula VII
- 63
- wherein R10 is selected from the group consisting of
- (i) an aromatic or heteroaromatic ring optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, amide, and ester moieties;
- (ii) an aliphatic or heteroaliphatic ring optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, ester, and an aromatic or heteroaromatic ring optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, alkoxy, halogen, trihalomethyl, carboxylate, nitro, and ester moieties;
- (iii) an amine of formula —(X1)n1—NX2X3, wherein X1 is selected from the group consisting of saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, or aliphatic ring moieties and wherein n1 is 0 or 1, and wherein X2 and X3 are independently selected from the group consisting of hydrogen, saturated or unsaturated alkyl, and five-membered or six-membered aromatic, heteroaromatic, or aliphatic ring moieties, or wherein X2 and X3 taken together form a 5-membered or 6-membered heteroaliphatic ring;
- (iv) a nitro of formula —NO2;
- (v) a bromine;
- (vi) a ketone of formula —(X4)n4—CO—X5, wherein X4 and X5 are independently selected from the group consisting of alkyl optionally substituted with halogen, trihalomethyl, carboxylate, nitro, ester, and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties, wherein said ring moieties are optionally substituted with one, two, or three substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester moieties and wherein n4 is 0 or 1;
- (vii) a carboxylic acid of formula —(X6)n6—COOH or ester of formula —(X7)n7—COO—X8, wherein X6, X7, and X8 and are independently selected from the group consisting of alkyl and five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties and wherein n6 and n7 are independently 0 or 1;
- (viii) a sulfonamide of formula —(X17)n17—SO2NX18X19, wherein X17 is selected from the group consisting of alkyl, five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, or ester, and wherein X18, and X19 are independently selected from the group consisting of hydrogen, alkyl, five-membered or six-membered aromatic, heteroaromatic, aliphatic, or heteroaliphatic ring moieties optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, or ester, and wherein X18 and X19 taken together form a five-membered or six-membered aliphatic or heteroaliphatic ring optionally substituted with one or more substituents independently selected from the group consisting of alkyl, halogen, trihalomethyl, carboxylate, nitro, and ester and where n17 is 0 or 1.
An oxindole compound, wherein said oxindole compound is selected from the group consisting of
- 65
Dependencies are inferred from the claim text.